SANTA MONICA, CA - Ocean Park Healthcare on Pico Boulevard faced serious medication management violations during an April inspection, with state surveyors documenting the facility's failure to administer a prescribed blood thinner to a resident with atrial fibrillation and multiple cardiac conditions.
Critical Medication Error Discovered
The inspection revealed that a resident with atrial fibrillation, a dangerous irregular heartbeat condition, did not receive their prescribed apixaban (Eliquis) blood thinner medication despite having an active physician's order. The resident had been transferred from Greater Los Angeles Community Hospital (GACH) on February 14, 2025, with clear documentation showing the blood thinner was part of their required medication regimen.
Medical records showed the resident had multiple serious cardiac conditions, including atherosclerotic heart disease, a history of stroke, and a cardiac pacemaker. For patients with atrial fibrillation, blood thinners are essential medications that prevent potentially fatal blood clots from forming. These clots can travel to the brain, causing strokes, or to other vital organs.
The medication was never transcribed to the facility's Medication Administration Record (MAR) for February 2025, meaning nursing staff had no record to follow for administering the drug. During the inspection, Licensed Vocational Nurse 1 acknowledged the serious consequences, stating that "the likely outcome for missing a blood thinner medication, the resident will have blood clots and complications that risks Resident 1's life."
Breakdown in Medication Reconciliation Process
The violation highlighted significant failures in the facility's medication reconciliation system, which is designed to ensure continuity of care during patient transfers. According to facility policy, nursing staff must compare hospital discharge medication lists with facility admission orders to prevent medication errors.
Multiple staff members were involved in the breakdown. The admitting Registered Nurse stated they "did not complete reconciliation because the resident was admitted after the RN's end of shift" and endorsed the admission process to the evening charge nurse. Licensed Vocational Nurse 3, who was responsible for entering medications into the electronic system, acknowledged that apixaban was listed in the transfer orders but admitted, "it might be an honest mistake omitting the apixaban/Eliquis from Resident 1's MAR."
The attending physician confirmed providing telephone approval for the resident's existing transfer medications, including the blood thinner, but the medication was never properly processed by nursing staff.
Medical Significance of Blood Thinner Therapy
Atrial fibrillation affects millions of Americans and significantly increases stroke risk. Patients with this condition have irregular heartbeats that can cause blood to pool in the heart's chambers, forming dangerous clots. Blood thinners like apixaban work by interfering with the body's clotting process, reducing the likelihood of clot formation by approximately 60-70% when taken consistently.
The consequences of missing blood thinner doses can be severe and immediate. Even short interruptions in anticoagulation therapy can allow clots to form within 24-48 hours. For patients with multiple risk factors like this resident - who had atrial fibrillation, previous stroke history, and heart disease - the risk becomes exponentially higher.
According to established medical protocols, blood thinner therapy should never be interrupted without careful medical supervision and usually requires bridging with other anticoagulants during any planned interruptions. Unplanned interruptions, like the one documented at this facility, represent serious patient safety events.
Systemic Issues in Medication Management
The inspection revealed broader problems with the facility's medication reconciliation system. The pharmacy supervisor confirmed they never received an order for the blood thinner, explaining that "pharmacy cannot dispense without orders." This indicates the error occurred during the initial medication transcription process rather than at the pharmacy level.
The facility's Director of Nursing acknowledged that "the medication is possibly omitted due to a failure to transcribe and medication reconciliation." This admission points to systemic issues in staff training, oversight procedures, and quality assurance measures during the critical admission process.
Standard nursing home protocols require that medication reconciliation be completed within 24 hours of admission, with supervisory review to catch any transcription errors. The facility's own policy mandates that nursing supervisors or the Director of Nursing review medication reconciliation after each admission, but this oversight apparently failed to occur.
Additional Issues Identified
The inspection also noted that the resident's Minimum Data Set assessment incorrectly indicated that high-risk anticoagulant medications were "not assessed," despite the resident being prescribed such medication. This represents an additional documentation failure that could have triggered appropriate monitoring protocols.
The facility's medication reconciliation policy, revised in April 2024, clearly outlines procedures for comparing external medication lists with facility orders, but the implementation of these procedures proved inadequate in this case.
These violations demonstrate critical gaps in medication safety protocols that nursing homes must maintain to protect vulnerable residents with complex medical conditions requiring precise medication management.
Full Inspection Report
The details above represent a summary of key findings. View the complete inspection report for Santa Monica Conv Ctr I from 2025-04-22 including all violations, facility responses, and corrective action plans.
💬 Join the Discussion
Comments are moderated. Please keep discussions respectful and relevant to nursing home care quality.